Amlodipine/Losartan Potassium/Rosuvastatin Calcium

氨氯地平/氯沙坦钾/瑞舒伐他汀钙

Report date: 2023/04/13 17:55:48

Base Information

Drug NameAmlodipine/Losartan Potassium/Rosuvastatin Calcium
Drug Alias Name氨氯地平/瑞舒伐他汀钙/氯沙坦钾Amlodipine/Rosuvastatin/LosartanAmlodipine/Losartan/Rosuvastatinamlodipine + losartan + rosuvastatin( Hanmi)
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsHMG-CoA reductase inhibitorsVoltage-gated calcium channel blockers
TargetsAngiotensin II Receptor Type 1Voltage-gated calcium channelHMG-CoA reductase
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2017/07/01
Country/TerritorySouth Korea
CombinationsYes Losartan PotassiumAmlodipine BesylateRosuvastatin Calcium
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHanmi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09D
Related LinksN/A